Dr David M Bierbrauer, MD | |
500 W 144th Ave Ste 230, Westminster, CO 80023-9328 | |
(303) 665-2603 | |
(303) 665-2605 |
Full Name | Dr David M Bierbrauer |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 25 Years |
Location | 500 W 144th Ave Ste 230, Westminster, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215917877 | NPI | - | NPPES |
50600354 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | CO 43680 (Colorado) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthopedic Centers Of Colorado | 2365714540 | 298 |
News Archive
Defects in a single gene can result in two immune system disorders that leave affected individuals vulnerable to frequent or unusually severe infections, according to new findings reported in the August issue of Nature Genetics.
Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.
Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects.
› Verified 1 days ago
Entity Name | Orthopedic Centers Of Colorado |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
Defects in a single gene can result in two immune system disorders that leave affected individuals vulnerable to frequent or unusually severe infections, according to new findings reported in the August issue of Nature Genetics.
Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.
Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David M Bierbrauer, MD 3455 Lutheran Pkwy Ste 105, Wheat Ridge, CO 80033-6028 Ph: (303) 665-2603 | Dr David M Bierbrauer, MD 500 W 144th Ave Ste 230, Westminster, CO 80023-9328 Ph: (303) 665-2603 |
News Archive
Defects in a single gene can result in two immune system disorders that leave affected individuals vulnerable to frequent or unusually severe infections, according to new findings reported in the August issue of Nature Genetics.
Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.
Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects.
› Verified 1 days ago
Dr. H Michael Tramutt, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7919 Zenobia St, Westminster, CO 80030 Phone: 303-430-8367 Fax: 303-430-4058 | |
Ian C Weber, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 Fax: 303-665-2605 | |
Dr. Tracy M Wolf, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 Fax: 303-665-2605 | |
Thomas A Mann, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 Fax: 303-665-2605 | |
Bianca Marie Seivley, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 | |
Dr. Thomas G Fry, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 Fax: 303-665-2605 |